Table 2 Viral suppression (≤ 30 copies/mL) following six month intervention period
Intervention % (n/N) | Control % (n/N) | Relative Risk (RR) | 95% CI for RR | p-value* | |
|---|---|---|---|---|---|
All women | 68.6 (35/51) | 63.0 (34/54) | 1.09 | 0.83, 1.44 | 0.52 |
FSW | 78.6 (33/42) | 63.2 (24/38) | 1.24 | 0.93, 1.66 | 0.10 |
Viremic at Baseline | 73.7 (28/38) | 59.5 (22/37) | 1.24 | 0.89, 1.72 | 0.50 |
FSW viremic at Baseline | 74.3 (26/35) | 46.2 (12/26) | 1.61 | 1.02, 2.55 | 0.04 |